Oral retinoids and pregnancy

被引：9

作者：

Chan, A

Hanna, M

Abbott, M

Keane, RJ

机构：

[1] S AUSTRALIAN HLTH COMMISS,PUBL & ENVIRONM HLTH SERV,DEPT DERMATOL,ADELAIDE,SA 5000,AUSTRALIA

[2] S AUSTRALIAN HLTH COMMISS,PUBL & ENVIRONM HLTH SERV,THERAPEUT GOODS SECT,ADELAIDE,SA 5000,AUSTRALIA

[3] WOMENS & CHILDRENS HOSP,S AUSTRALIAN BIRTH DEFECTS REGISTER,ADELAIDE,SA,AUSTRALIA

来源：

MEDICAL JOURNAL OF AUSTRALIA | 1996年 / 165卷 / 03期

关键词：

D O I：

10.5694/j.1326-5377.1996.tb124895.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The oral retinoids isotretinoin and etretinate are uniquely effective in the treatment of severe cystic acne and keratinisation disorders. Because of their known teratogenicity, there are strict prescription guidelines, but exposure during pregnancy still occurs. A dedicated effort by women and their clinicians is required, involving patient selection, education and informed consent, detailed contraceptive counselling, and careful monitoring and management, including pregnancy testing before commencement of therapy.

引用

页码：164 / 167

页数：4

共 19 条

[1]

[Anonymous], 1991, TERATOLOGY, V44, P1

[2]

*AUSTR DRUG EV COM, 1992, MED PREGN AUSTR CAT

[3]

CEYRAC DL, 1992, DERMATOLOGY, V184, P161

[4] RETINOID THERAPY - A REAL HAZARD FOR THE DEVELOPING EMBRYO [J].